Lindenwold Advisors INC Cuts Stock Position in Exponent, Inc. $EXPO

Lindenwold Advisors INC lessened its position in Exponent, Inc. (NASDAQ:EXPO) by 4.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,176 shares of the business services provider’s stock after selling 155 shares during the quarter. Lindenwold Advisors INC’s holdings in Exponent were worth $237,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Brooklyn Investment Group increased its holdings in Exponent by 10,200.0% during the 1st quarter. Brooklyn Investment Group now owns 309 shares of the business services provider’s stock worth $25,000 after purchasing an additional 306 shares during the period. UMB Bank n.a. increased its holdings in Exponent by 859.1% during the 1st quarter. UMB Bank n.a. now owns 633 shares of the business services provider’s stock worth $51,000 after purchasing an additional 567 shares during the period. Bessemer Group Inc. increased its holdings in Exponent by 103.3% during the 1st quarter. Bessemer Group Inc. now owns 681 shares of the business services provider’s stock worth $55,000 after purchasing an additional 346 shares during the period. SVB Wealth LLC purchased a new stake in Exponent during the 1st quarter worth about $80,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in Exponent by 8,092.9% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,147 shares of the business services provider’s stock worth $93,000 after purchasing an additional 1,133 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a report on Wednesday. One analyst has rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of “Hold”.

Exponent Stock Performance

NASDAQ:EXPO opened at $65.27 on Friday. The stock has a 50-day simple moving average of $69.96 and a 200-day simple moving average of $74.30. The stock has a market cap of $3.30 billion, a P/E ratio of 32.64 and a beta of 0.91. Exponent, Inc. has a 1 year low of $63.81 and a 1 year high of $115.75.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.04. The business had revenue of $132.87 million during the quarter, compared to analysts’ expectations of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The business’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.57 EPS. On average, equities research analysts predict that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Friday, September 5th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend was Friday, September 5th. Exponent’s dividend payout ratio is currently 60.00%.

Insider Activity

In other news, VP Joseph Sala sold 1,595 shares of the company’s stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total transaction of $112,670.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Catherine Corrigan sold 4,905 shares of the company’s stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $69.91, for a total value of $342,908.55. Following the transaction, the chief executive officer directly owned 82,753 shares of the company’s stock, valued at approximately $5,785,262.23. This represents a 5.60% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,396 shares of company stock valued at $803,636. Insiders own 1.60% of the company’s stock.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.